Oura Files for IPO Amid Rapid Revenue Growth and Expanding Health Platform

Oura, the company behind the biometric smart ring, has filed paperwork with the U.S. Securities and Exchange Commission to go public. The filing reveals a notable increase in revenue, rising from $697 million in the nine months ending June 30 last year to $1.2 billion in the same period this year. The company previously projected revenues of $500 million in 2024, around $1 billion in 2025, and close to $2 billion for the current year. Oura has sold approximately 3.6 million rings over the past year and reports about 5 million paid subscribers who access its broader health tracking services. The company also highlights a strong membership retention rate of roughly 85% over 12 months. The rings, priced between $350 and $400, function primarily as fitness trackers that monitor various biometric signals such as metabolism, heart rate, stress, and sleep patterns. These metrics are integrated with an app, positioning Oura as an "always-on health intelligence platform." Founded in Finland in 2013, Oura has expanded globally with offices including one in San Francisco. The company is reportedly aiming to raise $3 billion in its IPO and could be valued at around $16 billion, up from an $11 billion valuation last year. In its filing, Oura emphasizes its ambition to broaden its user base beyond traditional fitness tracking by enhancing clinical evidence and establishing deeper partnerships with health plans, employers, and care providers. The company also points to its extensive biometric dataset—covering over 50 health metrics and nearly 42 billion hours of physiological data—as a foundation for advancing AI and machine learning capabilities that improve personalization and predictive accuracy. However, Oura faces legal challenges. A proposed class action lawsuit alleges the company misled users regarding the accuracy of its sleep tracking, claiming the rings rely on AI-generated estimates rather than direct physiological signals. Oura has denied these allegations and stated it will defend itself in court. The IPO filing and growth trajectory underscore Oura's efforts to position itself as a key player in the consumer health technology space, leveraging data and AI to expand beyond basic wearable functions.